Skip to main content
Top
Published in: Molecular Cancer 1/2008

Open Access 01-12-2008 | Research

Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK

Authors: Klaus Dittmann, Claus Mayer, Rainer Kehlbach, H Peter Rodemann

Published in: Molecular Cancer | Issue 1/2008

Login to get access

Abstract

Background

To elucidate the role of src kinase in caveolin-1 driven internalization and nuclear transport of EGFR linked to regulation of DNA-repair in irradiated cells.

Results

Ionizing radiation resulted in src kinase stabilization, activation and subsequent src mediated caveolin-1 Y14- and EGFR Y845-phosphorylations. Both phosphorylations were radiation specific and could not be observed after treatment with EGF. Inhibition of EGFR by the antibody Erbitux resulted in a strong accumulation of caveolin/EGFR complexes within the cytoplasm, which could not be further increased by irradiation. Radiation-induced caveolin-1- and EGFR-phosphorylations were associated with nuclear EGFR transport and activation of DNA-PK, as detected by phosphorylation at T2609. Blockage of src activity by the specific inhibitor PP2, decreased nuclear transport of EGFR and inhibited caveolin-1- and DNA-PK-phosphorylation. Knockdown of src by specific siRNA blocked EGFR phosphorylation at Y845, phosphorylation of caveolin-1 at Y14 and abolished EGFR transport into the nucleus and phosphorylation of DNA-PK. Consequently, both knockdown of src by specific siRNA and also inhibition of src activity by PP2 resulted in an enhanced residual DNA-damage as quantified 24 h after irradiation and increased radiosensitivity.

Conclusion

Src kinase activation following irradiation triggered caveolin-1 dependent EGFR internalization into caveolae. Subsequently EGFR shuttled into the nucleus. As a consequence, inhibition of internalization and nuclear transport of EGFR blocked radiation-induced phosphorylation of DNA-PK and hampered repair of radiation-induced double strand breaks.
Appendix
Available only for authorised users
Literature
1.
go back to reference Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M: High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncology. 2007, 43 (2): 193-198. 10.1016/j.oraloncology.2006.02.009CrossRefPubMed Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M: High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncology. 2007, 43 (2): 193-198. 10.1016/j.oraloncology.2006.02.009CrossRefPubMed
2.
go back to reference Franovic A, Gunaratnam L, Smith K, Robert I, Patten D, Lee S: Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proceedings of the National Academy of Sciences of the United States of America. 2007, 104 (32): 13092-13097. 10.1073/pnas.0702387104PubMedCentralCrossRefPubMed Franovic A, Gunaratnam L, Smith K, Robert I, Patten D, Lee S: Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proceedings of the National Academy of Sciences of the United States of America. 2007, 104 (32): 13092-13097. 10.1073/pnas.0702387104PubMedCentralCrossRefPubMed
3.
go back to reference Toulany M, Dittmann K, Kruger M, Baumann M, Rodemann HP: Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiother Oncol. 2005, 76 (2): 143-150. 10.1016/j.radonc.2005.06.024CrossRefPubMed Toulany M, Dittmann K, Kruger M, Baumann M, Rodemann HP: Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiother Oncol. 2005, 76 (2): 143-150. 10.1016/j.radonc.2005.06.024CrossRefPubMed
4.
go back to reference Rodemann HP, Dittmann K, Toulany M: Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol. 2007, 83 (11): 781-791. 10.1080/09553000701769970CrossRefPubMed Rodemann HP, Dittmann K, Toulany M: Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol. 2007, 83 (11): 781-791. 10.1080/09553000701769970CrossRefPubMed
5.
go back to reference Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP: Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem. 2005, 280 (35): 31182-31189. 10.1074/jbc.M506591200CrossRefPubMed Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP: Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem. 2005, 280 (35): 31182-31189. 10.1074/jbc.M506591200CrossRefPubMed
6.
go back to reference Yotsumoto F, Yagi H, Suzuki SO, Oki E, Tsujioka H, Hachisuga T, Sonoda K, Kawarabayashi T, Mekada E, Miyamoto S: Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun. 2008, 365 (3): 555-561. 10.1016/j.bbrc.2007.11.015CrossRefPubMed Yotsumoto F, Yagi H, Suzuki SO, Oki E, Tsujioka H, Hachisuga T, Sonoda K, Kawarabayashi T, Mekada E, Miyamoto S: Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun. 2008, 365 (3): 555-561. 10.1016/j.bbrc.2007.11.015CrossRefPubMed
7.
go back to reference Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R: An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) – induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). Int J Mol Med. 2007, 20 (1): 3-10.PubMed Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R: An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) – induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). Int J Mol Med. 2007, 20 (1): 3-10.PubMed
8.
go back to reference Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB: Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997, 15 (10): 1191-1197. 10.1038/sj.onc.1201275CrossRefPubMed Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB: Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997, 15 (10): 1191-1197. 10.1038/sj.onc.1201275CrossRefPubMed
9.
go back to reference Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P: Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. Embo J. 1996, 15 (19): 5314-5325.PubMedCentralPubMed Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P: Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. Embo J. 1996, 15 (19): 5314-5325.PubMedCentralPubMed
10.
go back to reference Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L: Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem. 2006, 281 (36): 25903-25914. 10.1074/jbc.M603414200PubMedCentralCrossRefPubMed Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L: Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem. 2006, 281 (36): 25903-25914. 10.1074/jbc.M603414200PubMedCentralCrossRefPubMed
11.
go back to reference Evdonin AL, Guzhova IV, Margulis BA, Medvedeva ND: Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells. FEBS Lett. 2006, 580 (28–29): 6674-6678. 10.1016/j.febslet.2006.11.024CrossRefPubMed Evdonin AL, Guzhova IV, Margulis BA, Medvedeva ND: Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells. FEBS Lett. 2006, 580 (28–29): 6674-6678. 10.1016/j.febslet.2006.11.024CrossRefPubMed
12.
go back to reference Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, Goldkorn T: Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. J Biol Chem. 2006, 281 (20): 14486-14493. 10.1074/jbc.M509332200CrossRefPubMed Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, Goldkorn T: Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. J Biol Chem. 2006, 281 (20): 14486-14493. 10.1074/jbc.M509332200CrossRefPubMed
13.
go back to reference Bhola NE, Grandis JR: Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci. 2008, 13: 1857-1865. 10.2741/2805CrossRefPubMed Bhola NE, Grandis JR: Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci. 2008, 13: 1857-1865. 10.2741/2805CrossRefPubMed
14.
go back to reference Drube S, Stirnweiss J, Valkova C, Liebmann C: Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling. Cell Signal. 2006, 18 (10): 1633-1646. 10.1016/j.cellsig.2006.01.003CrossRefPubMed Drube S, Stirnweiss J, Valkova C, Liebmann C: Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling. Cell Signal. 2006, 18 (10): 1633-1646. 10.1016/j.cellsig.2006.01.003CrossRefPubMed
15.
go back to reference Wang Q, Zhu F, Wang Z: Identification of EGF receptor C-terminal sequences 1005–1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis. Exp Cell Res. 2007, 313 (15): 3349-3363. 10.1016/j.yexcr.2007.06.014CrossRefPubMed Wang Q, Zhu F, Wang Z: Identification of EGF receptor C-terminal sequences 1005–1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis. Exp Cell Res. 2007, 313 (15): 3349-3363. 10.1016/j.yexcr.2007.06.014CrossRefPubMed
16.
go back to reference Saito T, Okada S, Ohshima K, Yamada E, Sato M, Uehara Y, Shimizu H, Pessin JE, Mori M: Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology. 2004, 145 (9): 4232-4243. 10.1210/en.2004-0401CrossRefPubMed Saito T, Okada S, Ohshima K, Yamada E, Sato M, Uehara Y, Shimizu H, Pessin JE, Mori M: Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology. 2004, 145 (9): 4232-4243. 10.1210/en.2004-0401CrossRefPubMed
17.
go back to reference Toulany M, Baumann M, Rodemann HP: Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Mol Cancer Res. 2007, 5 (8): 863-872. 10.1158/1541-7786.MCR-06-0297CrossRefPubMed Toulany M, Baumann M, Rodemann HP: Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Mol Cancer Res. 2007, 5 (8): 863-872. 10.1158/1541-7786.MCR-06-0297CrossRefPubMed
18.
go back to reference Toulany M, Kasten-Pisula U, Brammer I, Wang S, Chen J, Dittmann K, Baumann M, Dikomey E, Rodemann HP: Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Clin Cancer Res. 2006, 12 (13): 4119-4126. 10.1158/1078-0432.CCR-05-2454CrossRefPubMed Toulany M, Kasten-Pisula U, Brammer I, Wang S, Chen J, Dittmann K, Baumann M, Dikomey E, Rodemann HP: Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Clin Cancer Res. 2006, 12 (13): 4119-4126. 10.1158/1078-0432.CCR-05-2454CrossRefPubMed
19.
go back to reference Tanos B, Pendergast AM: Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor. J Biol Chem. 2006, 281 (43): 32714-32723. 10.1074/jbc.M603126200CrossRefPubMed Tanos B, Pendergast AM: Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor. J Biol Chem. 2006, 281 (43): 32714-32723. 10.1074/jbc.M603126200CrossRefPubMed
20.
go back to reference Parton RG, Simons K: The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007, 8 (3): 185-194. 10.1038/nrm2122CrossRefPubMed Parton RG, Simons K: The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007, 8 (3): 185-194. 10.1038/nrm2122CrossRefPubMed
21.
go back to reference Cordes N, Frick S, Brunner TB, Pilarsky C, Grutzmann R, Sipos B, Kloppel G, McKenna WG, Bernhard EJ: Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene. 2007, 26 (48): 6851-6862. 10.1038/sj.onc.1210498CrossRefPubMed Cordes N, Frick S, Brunner TB, Pilarsky C, Grutzmann R, Sipos B, Kloppel G, McKenna WG, Bernhard EJ: Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene. 2007, 26 (48): 6851-6862. 10.1038/sj.onc.1210498CrossRefPubMed
22.
go back to reference Chen DJ, Nirodi CS: The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res. 2007, 13 (22 Pt 1): 6555-6560. 10.1158/1078-0432.CCR-07-1610CrossRefPubMed Chen DJ, Nirodi CS: The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res. 2007, 13 (22 Pt 1): 6555-6560. 10.1158/1078-0432.CCR-07-1610CrossRefPubMed
23.
go back to reference Wanner G, Mayer C, Kehlbach R, Rodemann HP, Dittmann K: Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. Radiother Oncol. 2008, 86 (3): 383-390. 10.1016/j.radonc.2007.10.041CrossRefPubMed Wanner G, Mayer C, Kehlbach R, Rodemann HP, Dittmann K: Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. Radiother Oncol. 2008, 86 (3): 383-390. 10.1016/j.radonc.2007.10.041CrossRefPubMed
24.
go back to reference Dittmann KH, Mayer C, Ohneseit PA, Raju U, Andratschke NH, Milas L, Rodemann HP: Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Int J Radiat Oncol Biol Phys. 2008, 70 (1): 203-212.CrossRefPubMed Dittmann KH, Mayer C, Ohneseit PA, Raju U, Andratschke NH, Milas L, Rodemann HP: Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Int J Radiat Oncol Biol Phys. 2008, 70 (1): 203-212.CrossRefPubMed
25.
go back to reference Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227 (5259): 680-685. 10.1038/227680a0CrossRefPubMed Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227 (5259): 680-685. 10.1038/227680a0CrossRefPubMed
26.
go back to reference Dittmann KH, Gueven N, Mayer C, Ohneseit P, Zell R, Begg AC, Rodemann HP: The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts. Radiat Res. 1998, 150 (6): 648-655. 10.2307/3579887CrossRefPubMed Dittmann KH, Gueven N, Mayer C, Ohneseit P, Zell R, Begg AC, Rodemann HP: The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts. Radiat Res. 1998, 150 (6): 648-655. 10.2307/3579887CrossRefPubMed
27.
go back to reference Lu Y, Li X, Liang K, Luwor R, Siddik ZH, Mills GB, Mendelsohn J, Fan Z: Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab. Cancer Res. 2007, 67 (17): 8240-8247. 10.1158/0008-5472.CAN-07-0589CrossRefPubMed Lu Y, Li X, Liang K, Luwor R, Siddik ZH, Mills GB, Mendelsohn J, Fan Z: Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab. Cancer Res. 2007, 67 (17): 8240-8247. 10.1158/0008-5472.CAN-07-0589CrossRefPubMed
28.
go back to reference Sato K, Sato A, Aoto M, Fukami Y: c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem Biophys Res Commun. 1995, 215 (3): 1078-1087. 10.1006/bbrc.1995.2574CrossRefPubMed Sato K, Sato A, Aoto M, Fukami Y: c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem Biophys Res Commun. 1995, 215 (3): 1078-1087. 10.1006/bbrc.1995.2574CrossRefPubMed
29.
go back to reference Chen BP, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H, Lobrich M, Shiloh Y, Chen DJ: Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem. 2007, 282 (9): 6582-6587. 10.1074/jbc.M611605200CrossRefPubMed Chen BP, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H, Lobrich M, Shiloh Y, Chen DJ: Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem. 2007, 282 (9): 6582-6587. 10.1074/jbc.M611605200CrossRefPubMed
30.
go back to reference Wang Q, Villeneuve G, Wang Z: Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. EMBO Rep. 2005, 6 (10): 942-948. 10.1038/sj.embor.7400491PubMedCentralCrossRefPubMed Wang Q, Villeneuve G, Wang Z: Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. EMBO Rep. 2005, 6 (10): 942-948. 10.1038/sj.embor.7400491PubMedCentralCrossRefPubMed
31.
go back to reference Mills IG: The interplay between clathrin-coated vesicles and cell signalling. Semin Cell Dev Biol. 2007, 18 (4): 459-470. 10.1016/j.semcdb.2007.07.001CrossRefPubMed Mills IG: The interplay between clathrin-coated vesicles and cell signalling. Semin Cell Dev Biol. 2007, 18 (4): 459-470. 10.1016/j.semcdb.2007.07.001CrossRefPubMed
32.
go back to reference Kirkham M, Parton RG: Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta. 2005, 1746 (3): 349-363. 10.1016/j.bbamcr.2005.11.005CrossRefPubMed Kirkham M, Parton RG: Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta. 2005, 1746 (3): 349-363. 10.1016/j.bbamcr.2005.11.005CrossRefPubMed
33.
go back to reference Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrichr RK: Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. Journal of Biological Chemistry. 2005, 280 (15): 14597-14604. 10.1074/jbc.M413287200CrossRefPubMed Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrichr RK: Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. Journal of Biological Chemistry. 2005, 280 (15): 14597-14604. 10.1074/jbc.M413287200CrossRefPubMed
34.
go back to reference Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P: Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol. 2005, 25 (15): 6391-6403. 10.1128/MCB.25.15.6391-6403.2005PubMedCentralCrossRefPubMed Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P: Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol. 2005, 25 (15): 6391-6403. 10.1128/MCB.25.15.6391-6403.2005PubMedCentralCrossRefPubMed
35.
go back to reference Zhu S, Bjorge JD, Fujita DJ: PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res. 2007, 67 (21): 10129-10137. 10.1158/0008-5472.CAN-06-4338CrossRefPubMed Zhu S, Bjorge JD, Fujita DJ: PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res. 2007, 67 (21): 10129-10137. 10.1158/0008-5472.CAN-06-4338CrossRefPubMed
36.
go back to reference Dittmann K, Mayer C, Wanner G, Kehlbach R, Rodemann HP: The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation. Radiother Oncol. 2007, 84 (3): 328-334. 10.1016/j.radonc.2007.07.006CrossRefPubMed Dittmann K, Mayer C, Wanner G, Kehlbach R, Rodemann HP: The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation. Radiother Oncol. 2007, 84 (3): 328-334. 10.1016/j.radonc.2007.07.006CrossRefPubMed
37.
go back to reference Dittmann K, Mayer C, Rodemann HP: Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol. 2005, 76 (2): 157-161. 10.1016/j.radonc.2005.06.022CrossRefPubMed Dittmann K, Mayer C, Rodemann HP: Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol. 2005, 76 (2): 157-161. 10.1016/j.radonc.2005.06.022CrossRefPubMed
Metadata
Title
Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK
Authors
Klaus Dittmann
Claus Mayer
Rainer Kehlbach
H Peter Rodemann
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2008
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-7-69

Other articles of this Issue 1/2008

Molecular Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine